Greater effectiveness of phenoxybenzamine in blocking vasoconstrictor responses to central sympathetic stimulation than to norepinephrine administration in the cat.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000502:physiology; D002415:Cats; D004558:Electric Stimulation; D005260:Female; D006614:Hindlimb / Q000294:innervation; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D010477:Perfusion; D010643:Phenoxybenzamine / Q000008:administration & dosage / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000502:physiology; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D011433:Propranolol; D009638:Norepinephrine; D010646:Phentolamine